https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-income-q2-2024/ 2024-07-29T08:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-msd-keytruda-regimen/ 2024-07-29T08:08:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/osteoporosis-ai-model-diagnosis/ 2024-07-29T07:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-securechek-ai/ 2025-01-22T07:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-proposes-overhaul-of-perioperative-lung-cancer-trials/ 2024-08-01T10:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-backs-wegovy-cardiovascular-label-update-as-novo-seeks-eu-coverage/ 2024-07-26T15:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sun-pharmas-jak-inhibitor-for-alopecia/ 2024-07-26T15:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-wins-positive-chmp-opinion-to-amend-imvanex-approval/ 2024-07-26T14:59:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-the-effort-to-rescue-a-gene-therapy-for-a-rare-disease/ 2024-07-31T10:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cue-biopharma-downsizes-to-focus-on-autoimmune-pipeline/ 2024-07-26T13:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-h1-2024-net-income/ 2024-07-26T10:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mankind-pharma-to-acquire-bsv/ 2024-07-26T10:07:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-q2-net-earnings/ 2024-07-26T08:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-pfizer-haemophilia-therapy/ 2024-07-26T16:05:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ac-immune-wins-fda-fast-track-for-alzheimers-vaccine-candidate/ 2024-07-26T18:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-outlines-461m-for-ex-us-rights-to-day-ones-glioma-therapy/ 2024-07-25T15:34:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-launches-ustekinumab-biosimilar-in-europe/ 2024-07-25T15:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/consynance-wins-fda-designation-for-prader-willi-syndrome-therapy/ 2024-07-25T15:00:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-biomarin-brineura/ 2024-07-25T10:18:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-boehringer-drug/ 2024-07-25T10:11:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dren-bio-novartis-antibodies-cancer/ 2024-07-25T08:14:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-approves-pfizer-biontech-vaccine/ 2024-07-25T08:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioatla-receives-fda-fast-track-designation-for-ozuriftamab-vedotin/ 2024-07-25T15:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-potential-of-3d-printing-in-drug-development-and-delivery/ 2024-07-24T15:42:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telixs-prostate-cancer-imaging-kit-set-for-fda-review/ 2024-07-24T14:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-study-suggests-car-t-therapy-monitoring-time-could-be-slashed/ 2024-07-31T10:25:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-grows-oncology-portfolio-with-pinetrees-egfr-degrader/ 2024-07-24T13:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/standing-ovation-gilead-lenacapavir-aids2024/ 2024-07-24T12:42:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/triastek-biontech-rna-therapeutics/ 2024-07-24T10:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-biologics-manufacturing-facility/ 2024-07-24T10:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-new-frontiers-of-supply-chain-disruption-and-how-pharma-firms-are-responding/ 2024-07-24T09:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-gtri-gene-therapy-parkinsons/ 2024-07-26T16:09:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-novo-nordisk-semaglutide-approval/ 2024-07-24T08:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jj-forecast-dominate-bite-market/ 2024-07-24T07:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sionna-abbvie-deal-cf/ 2024-07-24T07:34:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-mesoblasts-latest-bla-for-paediatric-gvhd-cell-therapy/ 2024-12-18T16:17:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-gives-thumbs-down-to-bluebirds-fertility-support-programme/ 2024-07-23T17:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-drops-addexs-epilepsy-treatment-after-flunking-in-phase-ii/ 2024-07-23T14:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-raises-398m-to-advance-kidney-and-brain-cancer-radiotherapies/ 2024-07-23T14:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-5-doing-digital-deals-in-life-sciences-deal-structures-terms-and-series-conclusions/ 2025-03-28T16:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agilent-to-acquire-biovectra/ 2024-07-23T10:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-samsung-bioepis/ 2024-07-23T10:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-snda-depression/ 2024-07-23T08:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/grunenthal-valinor-pharma/ 2024-07-23T08:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unaids-gilead-call-lenacapavir-generics-available/ 2024-07-23T08:08:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/how-a-potential-harris-presidency-could-influence-us-healthcare/ 2024-07-22T16:59:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-the-challenges-of-bringing-cell-and-gene-therapies-to-market/ 2024-07-22T16:25:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ilumetri-and-ebglyss-spur-almiralls-growth-in-dermatology/ 2024-07-22T14:31:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/siga-scores-hhs-contract-for-smallpox-vaccine-tpoxx-worth-113m/ 2024-07-22T14:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/altamiras-drug-delivering-nanoparticles-could-treat-aaa/ 2024-07-22T15:55:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-cell-therapy/ 2024-12-18T16:26:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-accord-relugolix/ 2024-07-22T10:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/how-nvidia-grew-with-the-healthcare-market-instead-of-pushing-into-it/ 2024-07-22T11:32:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rusan-pharmas-api-plant-in-ankleshwar-receives-us-fda-gmp-approval/ 2024-07-22T09:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gro-biosciences-gout-treatment/ 2024-07-22T08:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-gsk-blenrep-maa/ 2024-07-22T08:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-lupin-zentiva-raltegravir/ 2024-07-22T08:00:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iteos-therapeutics-patent-activity/ 2024-07-21T18:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/certara-patent-activity/ 2024-07-21T18:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kiniksa-pharmaceuticals-patent-activity/ 2024-07-21T18:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicover-patent-activity/ 2024-07-21T18:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orion-patent-activity/ 2024-07-21T18:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/y-mabs-therapeutics-patent-activity/ 2024-07-21T18:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oramed-pharmaceuticals-patent-activity/ 2024-07-21T18:09:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dechra-pharmaceuticals-patent-activity/ 2024-07-21T18:09:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oscotec-patent-activity/ 2024-07-21T18:08:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medios-patent-activity/ 2024-07-21T18:08:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amicogen-patent-activity/ 2024-07-21T18:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hangzhou-tigermed-consulting-patent-activity/ 2024-07-21T18:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharming-group-patent-activity/ 2024-07-21T18:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/travere-therapeutics-patent-activity/ 2024-07-21T18:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/healios-patent-activity/ 2024-07-21T18:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tg-therapeutics-patent-activity/ 2024-07-21T18:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seikagaku-patent-activity/ 2024-07-21T18:06:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalyst-pharmaceuticals-patent-activity/ 2024-07-21T18:06:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agiliti-patent-activity/ 2024-07-21T18:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eubiologics-patent-activity/ 2024-07-21T18:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anterogen-patent-activity/ 2024-07-21T18:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocugen-patent-activity/ 2024-07-21T18:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jetema-patent-activity/ 2024-07-21T18:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurobindo-pharma-patent-activity/ 2024-07-21T18:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omniab-patent-activity/ 2024-07-21T18:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/euroapi-patent-activity/ 2024-07-21T18:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nuvalent-patent-activity/ 2024-07-21T18:03:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prokidney-patent-activity/ 2024-07-21T18:03:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organon-co-patent-activity/ 2024-07-21T18:03:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hygeia-healthcare-patent-activity/ 2024-07-21T18:03:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tarsus-pharmaceuticals-patent-activity/ 2024-07-21T18:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aerovate-therapeutics-patent-activity/ 2024-07-21T18:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zentalis-pharmaceuticals-patent-activity/ 2024-07-21T18:02:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hlb-patent-activity/ 2024-07-21T18:02:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mind-medicine-mindmed-patent-activity/ 2024-07-21T18:01:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nuvation-bio-patent-activity/ 2024-07-21T18:01:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/covetrus-patent-activity/ 2024-07-21T18:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verve-therapeutics-patent-activity/ 2024-07-21T18:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/erasca-patent-activity/ 2024-07-21T18:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sana-biotechnology-patent-activity/ 2024-07-21T18:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avantor-patent-activity/ 2024-07-21T17:59:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/entrada-therapeutics-patent-activity/ 2024-07-21T17:59:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mirum-pharmaceuticals-patent-activity/ 2024-07-21T17:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alphamab-oncology-patent-activity/ 2024-07-21T17:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atai-life-sciences-patent-activity/ 2024-07-21T17:58:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocumension-therapeutics-patent-activity/ 2024-07-21T17:58:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kronos-bio-patent-activity/ 2024-07-21T17:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/akero-therapeutics-patent-activity/ 2024-07-21T17:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/generation-bio-patent-activity/ 2024-07-21T17:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkarta-patent-activity/ 2024-07-21T17:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stoke-therapeutics-patent-activity/ 2024-07-21T17:56:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gossamer-bio-patent-activity/ 2024-07-21T17:56:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/i-mab-patent-activity/ 2024-07-21T17:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/everest-medicines-patent-activity/ 2024-07-21T17:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/harmony-biosciences-patent-activity/ 2024-07-21T17:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioxcel-therapeutics-patent-activity/ 2024-07-21T17:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/veru-patent-activity/ 2024-07-21T17:54:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/igm-biosciences-patent-activity/ 2024-07-21T17:54:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/repare-therapeutics-patent-activity/ 2024-07-21T17:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-patent-activity/ 2024-07-21T17:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shattuck-labs-patent-activity/ 2024-07-21T17:53:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-patent-activity/ 2024-07-21T17:53:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-patent-activity/ 2024-07-21T17:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tango-therapeutics-patent-activity/ 2024-07-21T17:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abl-bio-patent-activity/ 2024-07-21T17:52:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bridgebio-pharma-patent-activity/ 2024-07-21T17:52:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hugel-patent-activity/ 2024-07-21T17:52:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bnc-korea-patent-activity/ 2024-07-21T17:52:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/relay-therapeutics-patent-activity/ 2024-07-21T17:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bolt-biotherapeutics-patent-activity/ 2024-07-21T17:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rhythm-pharmaceuticals-patent-activity/ 2024-07-21T17:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fulcrum-therapeutics-patent-activity/ 2024-07-21T17:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/black-diamond-therapeutics-patent-activity/ 2024-07-21T17:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/morphic-holding-patent-activity/ 2024-07-21T17:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/keros-therapeutics-patent-activity/ 2024-07-21T17:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ideaya-biosciences-patent-activity/ 2024-07-21T17:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pliant-therapeutics-patent-activity/ 2024-07-21T17:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rapt-therapeutics-patent-activity/ 2024-07-21T17:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-patent-activity/ 2024-07-21T17:48:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adicet-bio-patent-activity/ 2024-07-21T17:48:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kezar-life-sciences-patent-activity/ 2024-07-21T17:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olema-pharmaceuticals-patent-activity/ 2024-07-21T17:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-patent-activity/ 2024-07-21T17:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/roivant-sciences-patent-activity/ 2024-07-21T17:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-patent-activity/ 2024-07-21T17:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beyondspring-patent-activity/ 2024-07-21T17:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-patent-activity/ 2024-07-21T17:46:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aptabio-therapeutics-patent-activity/ 2024-07-21T17:46:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/quince-therapeutics-patent-activity/ 2024-07-21T17:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zai-lab-patent-activity/ 2024-07-21T17:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/betta-pharmaceuticals-patent-activity/ 2024-07-21T17:45:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmv-pharmaceuticals-patent-activity/ 2024-07-21T17:45:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxcyte-patent-activity/ 2024-07-21T17:44:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-patent-activity/ 2024-07-21T17:44:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharmaron-beijing-patent-activity/ 2024-07-21T17:44:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evolus-patent-activity/ 2024-07-21T17:44:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-patent-activity/ 2024-07-21T17:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascentage-pharma-group-international-patent-activity/ 2024-07-21T17:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shin-nippon-biomedical-laboratories-patent-activity/ 2024-07-21T17:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mezzion-pharma-patent-activity/ 2024-07-21T17:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/g1-therapeutics-patent-activity/ 2024-07-21T17:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iqvia-patent-activity/ 2024-07-21T17:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexon-patent-activity/ 2024-07-21T17:42:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dong-e-e-jiao-patent-activity/ 2024-07-21T17:42:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acadia-pharmaceuticals-patent-activity/ 2024-07-21T17:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-patent-activity/ 2024-07-21T17:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fate-therapeutics-patent-activity/ 2024-07-21T17:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siegfried-patent-activity/ 2024-07-21T17:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apeloa-pharmaceutical-patent-activity/ 2024-07-21T17:40:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adma-biologics-patent-activity/ 2024-07-21T17:40:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mochida-pharmaceutical-patent-activity/ 2024-07-21T17:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/suheung-capsule-patent-activity/ 2024-07-21T17:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhangzhou-pien-tze-huang-pharmaceutical-patent-activity/ 2024-07-21T17:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibrogen-patent-activity/ 2024-07-21T17:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharmablock-sciences-nanjing-patent-activity/ 2024-07-21T17:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/perrigo-co-patent-activity/ 2024-07-21T17:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/divis-laboratories-patent-activity/ 2024-09-16T07:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/karyopharm-therapeutics-patent-activity/ 2024-07-21T17:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/st-pharm-patent-activity/ 2024-07-21T17:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celltrion-patent-activity/ 2024-07-21T17:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cassava-sciences-patent-activity/ 2024-07-21T17:35:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-health-tech-patent-activity/ 2024-07-21T17:35:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adaptive-biotechnologies-patent-activity/ 2024-07-21T17:35:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ani-pharmaceuticals-patent-activity/ 2024-07-21T17:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nektar-therapeutics-patent-activity/ 2024-07-21T17:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/urogen-pharma-patent-activity/ 2024-07-21T17:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocket-pharmaceuticals-patent-activity/ 2024-07-21T17:34:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/suzuken-patent-activity/ 2024-07-21T17:34:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celldex-therapeutics-patent-activity/ 2024-07-21T17:34:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/maxcyte-patent-activity/ 2024-07-21T17:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hua-medicine-shanghai-patent-activity/ 2024-07-21T17:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huons-global-patent-activity/ 2024-07-21T17:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jcr-pharmaceuticals-patent-activity/ 2024-07-21T17:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crinetics-pharmaceuticals-patent-activity/ 2024-07-21T17:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hansa-biopharma-patent-activity/ 2024-07-21T17:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dongkook-pharmaceutical-patent-activity/ 2024-07-21T17:31:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shanghai-raas-blood-products-patent-activity/ 2024-07-21T17:31:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nippon-shinyaku-patent-activity/ 2024-07-21T17:31:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/essa-pharma-patent-activity/ 2024-07-21T17:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alteogen-patent-activity/ 2024-07-21T17:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kissei-pharmaceutical-patent-activity/ 2024-07-21T17:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascletis-pharma-patent-activity/ 2024-07-21T17:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syndax-pharmaceuticals-patent-activity/ 2024-07-21T17:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chengdu-kanghong-pharmaceuticals-group-patent-activity/ 2024-07-21T17:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/swedish-orphan-biovitrum-patent-activity/ 2024-07-21T17:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esperion-therapeutics-patent-activity/ 2024-07-21T17:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coherus-biosciences-patent-activity/ 2024-07-21T17:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ergomed-patent-activity/ 2024-07-21T17:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-patent-activity/ 2024-07-21T17:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharmaessentia-patent-activity/ 2024-07-21T17:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avacta-group-patent-activity/ 2024-07-21T17:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aclaris-therapeutics-patent-activity/ 2024-07-21T17:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atara-biotherapeutics-patent-activity/ 2024-07-21T17:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amneal-pharmaceuticals-patent-activity/ 2024-07-21T17:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultragenyx-pharmaceutical-patent-activity/ 2024-07-21T17:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ironwood-pharmaceuticals-patent-activity/ 2024-07-21T17:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shandong-buchang-pharmaceutical-patent-activity/ 2024-07-21T17:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioarctic-patent-activity/ 2024-07-21T17:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/supernus-pharmaceuticals-patent-activity/ 2024-07-21T17:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bluebird-bio-patent-activity/ 2024-07-21T17:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gemvax-kael-patent-activity/ 2024-07-21T17:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pharmaengine-patent-activity/ 2024-07-21T17:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emergent-biosolutions-patent-activity/ 2024-07-21T17:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kaken-pharmaceutical-patent-activity/ 2024-07-21T17:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/microbio-patent-activity/ 2024-07-21T17:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biotage-patent-activity/ 2024-07-21T17:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kintor-pharmaceutical-patent-activity/ 2024-07-21T17:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkmax-patent-activity/ 2024-07-21T17:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innoviva-patent-activity/ 2024-07-21T17:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-patent-activity/ 2024-07-21T17:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cansino-biologics-patent-activity/ 2024-07-21T17:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptidream-patent-activity/ 2024-07-21T17:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siga-technologies-patent-activity/ 2024-07-21T17:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pacira-biosciences-patent-activity/ 2024-07-21T17:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apellis-pharmaceuticals-patent-activity/ 2024-07-21T17:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revance-therapeutics-patent-activity/ 2024-07-21T17:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curis-patent-activity/ 2024-07-21T17:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shijiazhuang-yiling-pharmaceutical-patent-activity/ 2024-07-21T17:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calliditas-therapeutics-patent-activity/ 2024-07-21T17:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/madrigal-pharmaceuticals-patent-activity/ 2024-07-21T17:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuren-pharmaceuticals-patent-activity/ 2024-07-21T17:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/collegium-pharmaceutical-patent-activity/ 2024-07-21T17:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-patent-activity/ 2024-07-21T17:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olix-pharmaceuticals-patent-activity/ 2024-07-21T17:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heron-therapeutics-patent-activity/ 2024-07-21T17:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-patent-activity/ 2024-07-21T17:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amphastar-pharmaceuticals-patent-activity/ 2024-07-21T17:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/faes-farma-patent-activity/ 2024-07-21T17:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chimerix-patent-activity/ 2024-07-21T17:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jeil-pharmaceutical-patent-activity/ 2024-07-21T17:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-partners-patent-activity/ 2024-07-21T17:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxart-patent-activity/ 2024-07-21T17:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kodiak-sciences-patent-activity/ 2024-07-21T17:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/akebia-therapeutics-patent-activity/ 2024-07-21T17:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/piramal-enterprises-patent-activity/ 2024-07-21T17:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gni-group-patent-activity/ 2024-07-21T17:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/matsuda-sangyo-patent-activity/ 2024-07-21T17:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regenxbio-patent-activity/ 2024-07-21T17:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medipal-patent-activity/ 2024-07-21T17:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/community-health-systems-patent-activity/ 2024-07-21T17:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-patent-activity/ 2024-07-21T17:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huadong-medicine-patent-activity/ 2024-07-21T17:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeuticsmd-patent-activity/ 2024-07-21T17:11:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-patent-activity/ 2024-07-21T17:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cantargia-patent-activity/ 2024-07-21T17:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/assembly-biosciences-patent-activity/ 2024-07-21T17:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daewon-pharmaceutical-patent-activity/ 2024-07-21T17:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/handok-patent-activity/ 2024-07-21T17:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yifan-pharmaceutical-patent-activity/ 2024-07-21T17:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ecofibre-patent-activity/ 2024-07-21T17:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aprea-therapeutics-patent-activity/ 2024-07-21T17:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sawai-group-patent-activity/ 2024-07-21T17:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nextcure-patent-activity/ 2024-07-21T17:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eutilex-patent-activity/ 2024-07-21T17:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shenzhen-hepalink-pharmaceutical-group-patent-activity/ 2024-07-21T17:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tonghua-dongbao-pharmaceutical-patent-activity/ 2024-07-21T17:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipca-laboratories-patent-activity/ 2024-07-21T17:06:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athersys-patent-activity/ 2024-07-21T17:06:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lees-pharmaceutical-patent-activity/ 2024-07-21T17:06:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medipost-patent-activity/ 2024-07-21T17:06:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tianjin-chase-sun-pharmaceutical-patent-activity/ 2024-07-21T17:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takara-patent-activity/ 2024-07-21T16:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-gains-ema-validation-for-opdivo-yervoy-combo-in-liver-cancer/ 2024-07-19T19:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tech-leaders-125m-boosts-parker-institutes-immunotherapy-research/ 2024-07-29T19:53:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-offers-humira-biosimilar-at-92-discount/ 2024-07-19T15:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exscientia-acquires-oral-cdk7-inhibitor-for-20m-plans-breast-cancer-trial/ 2024-07-19T14:51:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hiv-aids-conference-july-2024/ 2024-07-19T14:13:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rona-funds-sirna-pipeline/ 2024-07-19T10:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meitheal-rights-contepo-nabriva/ 2024-07-19T08:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-deciphera-maa-review/ 2024-07-19T07:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ardelyx-sues-cms-over-revamped-kidney-disease-drug-payment-bundle/ 2024-07-19T10:25:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-launches-new-rare-disease-innovation-hub/ 2024-07-18T18:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-eyes-nubeqas-label-expansion-in-prostate-cancer-following-phase-iii-win/ 2024-07-18T18:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-net-income-q2-2024/ 2024-07-18T10:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytoreason-secures-80m-investment/ 2024-07-18T10:00:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inside-canary-wharfs-infectious-disease-testing-facility/ 2024-07-18T11:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-q2-net-earnings/ 2024-07-18T08:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-pierre-fabre-vibegron-oab/ 2024-07-18T08:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-priority-review-advances-ataras-tabelecleucel-for-viral-infection/ 2024-07-17T20:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/gene-therapy-how-the-cro-of-veristat-cut-trial-database-costs-by-30/ 2025-04-22T17:05:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/finding-the-right-solution-and-partner-for-your-drug-products-commercial-supply-chain/ 2024-07-17T15:11:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-humira-loss-exclusivity-missed-opportunity-competitors/ 2024-07-17T14:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/catalym-secures-150m-to-advance-gdf-15-targeting-immune-modulator/ 2024-07-17T14:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cardurion-closes-260m-in-series-b-to-develop-cardiovascular-pipeline/ 2024-07-17T14:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-biosecure-act-destabilise-pharmaceutical-industry/ 2024-07-19T12:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scorpion-funding-oncology-pipeline/ 2024-07-17T10:24:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-zai-lab-gmg/ 2024-07-17T10:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-crl-orexo-nda/ 2024-07-17T08:35:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/upperton-mhra-manufacturing-nottingham/ 2024-07-17T08:28:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drug-development-costs-predicted-to-soar-as-biosecure-act-gains-momentum/ 2024-07-26T14:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revolution-sets-sights-on-phase-iii-trial-for-pan-ras-inhibitor/ 2024-07-16T16:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/german-cdmo-outlays-980m-on-glp-1-manufacturing-expansion/ 2024-07-16T15:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kyverna-wins-rmat-designation-for-stiff-person-syndrome-for-cell-therapy-candidate/ 2024-12-18T16:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sotio-partners-with-biocytogen-to-expand-adc-oncology-pipeline/ 2024-07-16T15:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asceneuron-100m-neurodegenerative-therapies/ 2024-07-16T10:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/non-small-cell-lung-cancer-the-global-clinical-trials-landscape-2024/ 2024-07-16T09:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sii-oxford-university-vaccine-cote-d-ivoire/ 2024-07-16T09:32:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sumitomo-pharma-dsp-5336-aml/ 2024-07-16T08:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-amolyt-acquisition/ 2024-07-16T08:11:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurora-cannabis-gets-grant-for-identifying-and-breeding-cannabis-plants-with-day-length-neutral-phenotype/ 2024-07-16T02:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sonnet-biotherapeutics-gets-grant-for-il-12-albumin-binding-domain-fusion-protein/ 2024-07-16T02:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkarta-gets-grant-for-genetically-engineered-nk-cells-for-cd70-targeted-immunotherapy/ 2024-07-16T02:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scpharmaceuticals-gets-grant-for-liquid-pharmaceutical-formulation-of-furosemide-for-treating-various-conditions/ 2024-07-16T02:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/american-well-gets-grant-for-telemedicine-device-for-capturing-patient-data-and-initiating-communication-sessions/ 2024-07-16T02:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athira-pharma-gets-grant-for-treatment-of-parkinson-s-disease-and-lewy-body-disease/ 2024-07-16T02:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sana-biotechnology-gets-grant-for-engineered-t-cell-with-reduced-mhc-expression-and-car/ 2024-07-16T02:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inventiva-gets-grant-for-chemical-compounds-with-specific-formula/ 2024-07-16T02:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaptysbio-gets-grant-for-treatment-of-autoimmune-disease-using-il-33-binding-protein/ 2024-07-16T02:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kezar-life-sciences-gets-grant-for-method-for-preparing-compound-g-and-precursors-thereof/ 2024-07-16T02:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcutis-biotherapeutics-gets-grant-for-topical-roflumilast-composition-for-treating-inflammatory-disorders/ 2024-07-16T02:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/entrada-therapeutics-gets-grant-for-treatment-of-mitochondrial-neurogastrointestinal-encephalopathy-syndrome-using-specific-compounds/ 2024-07-16T02:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bukwang-pharmaceutical-gets-grant-for-pulsatile-release-pharmaceutical-composition-for-parkinson-s-disease-management/ 2024-07-16T02:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/photocure-gets-grant-for-photodynamic-therapy-for-non-muscle-invasive-bladder-cancer/ 2024-07-16T02:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dechra-pharmaceuticals-gets-grant-for-non-aqueous-composition-containing-azithromycin-for-felines/ 2024-07-16T02:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/symbio-pharmaceuticals-gets-grant-for-proton-exchange-membrane-for-self-regenerating-fuel-cell/ 2024-07-16T02:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tiziana-life-sciences-gets-grant-for-nanoparticle-delivery-of-dactinomycin-for-treating-myelodysplastic-syndrome/ 2024-07-16T02:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arup-laboratories-gets-grant-for-method-of-separating-free-target-analyte-from-protein-bound-analyte/ 2024-07-16T02:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evofem-biosciences-gets-grant-for-contraceptive-microbicide-composition-enhancing-efficacy-of-preventing-pregnancy/ 2024-07-16T02:51:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hikma-pharmaceuticals-gets-grant-for-nasal-spray-formulation-containing-naloxone-for-opioid-treatment/ 2024-07-16T02:51:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/helixmith-gets-grant-for-pharmaceutical-composition-for-treating-adhd/ 2024-07-16T02:51:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fennec-pharmaceuticals-gets-grant-for-pharmaceutical-composition-for-reducing-ototoxicity-in-cancer-treatment/ 2024-07-16T02:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptidream-gets-grant-for-method-for-producing-a-peptide/ 2024-07-16T02:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/starpharma-gets-grant-for-cancer-treatment-using-dendrimers-with-specific-chemical-structure/ 2024-07-16T02:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blue-cross-and-blue-shield-association-gets-grant-for-customized-geographic-visualization-system-for-population-information/ 2024-07-16T02:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chimerix-gets-grant-for-antiviral-compounds-for-treating-viral-infections/ 2024-07-16T02:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/madrigal-pharmaceuticals-gets-grant-for-treatment-of-fatty-liver-disease-using-specific-compound/ 2024-07-16T02:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tenax-therapeutics-gets-grant-for-treatment-of-pulmonary-hypertension-heart-failure-with-levosimendan/ 2024-07-16T02:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regenxbio-gets-grant-for-treating-mps-ii-by-delivering-hids-to-cns/ 2024-07-16T02:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lumos-pharma-gets-grant-for-pediatric-growth-hormone-deficiency-treatment-tablet/ 2024-07-16T02:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/homology-medicines-gets-grant-for-packaging-system-for-aav-expressing-pah-gene/ 2024-07-16T02:50:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioxcel-therapeutics-gets-grant-for-high-dose-dexmedetomidine-for-treating-agitation-without-sedation/ 2024-07-16T02:50:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocon-gets-grant-for-humanized-igg1-antibody-binding-to-human-cd6/ 2024-07-16T02:50:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxcyte-gets-grant-for-patent-granted-for-immunogenic-compositions-containing-non-natural-amino-acids/ 2024-07-16T02:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stealth-biotherapeutics-gets-grant-for-treating-or-preventing-drug-induced-neuropathy-to-increase-chemotherapy-dose/ 2024-07-16T02:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kura-oncology-gets-grant-for-treating-leukemia-with-menin-inhibitors/ 2024-07-16T02:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adc-therapeutics-gets-grant-for-antibody-binding-to-il13ra2-for-medical-uses/ 2024-07-16T02:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/infinity-pharmaceuticals-gets-grant-for-treatment-of-hematological-cancer-using-specific-pharmaceutical-compositions/ 2024-07-16T02:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lupin-gets-grant-for-treatment-of-cancer-by-inhibiting-prmt5-enzyme/ 2024-07-16T02:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avacta-group-gets-grant-for-polypeptide-with-n32g-mutation-and-heterologous-peptides/ 2024-07-16T02:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/henry-ford-health-system-gets-grant-for-treatment-of-cardiovascular-disorders-with-microrna-126-in-diabetic-stroke-patients/ 2024-07-16T02:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cardiff-oncology-gets-grant-for-combination-treatment-for-lung-and-gastric-cancer/ 2024-07-16T02:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ginkgo-bioworks-gets-grant-for-modified-aav-capsid-protein-for-virus-vectors/ 2024-07-16T02:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melinta-therapeutics-gets-grant-for-antimicrobial-compound-preparation-using-boronate-derivatives/ 2024-07-16T02:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kyorin-gets-grant-for-antiviral-compound-for-picornavirus-genus-specifically-rhinovirus/ 2024-07-16T02:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanbio-gets-grant-for-method-for-inducing-polarization-in-mesenchymal-stem-cells/ 2024-07-16T02:50:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bridgebio-pharma-gets-grant-for-high-load-tablet-formulation-of-ag10-with-specific-excipients/ 2024-07-16T02:50:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avantor-gets-grant-for-pump-assembly-with-display-strain-relief-and-access-panel/ 2024-07-16T02:50:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalent-gets-grant-for-system-for-dosing-pharmaceutical-formulation-based-on-density-measurement/ 2024-07-16T02:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alkermes-gets-grant-for-compounds-for-treating-narcolepsy-or-cataplexy/ 2024-07-16T02:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genscript-biotech-gets-grant-for-anti-lag-3-construct-with-single-domain-antibody/ 2024-07-16T02:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iqvia-gets-grant-for-method-to-determine-reduced-cohort-criteria-from-patient-data/ 2024-07-16T02:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memorial-sloan-kettering-cancer-center-gets-grant-for-monoclonal-antibodies-for-cancer-treatment-by-increasing-t-cell-activation/ 2024-07-16T02:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otsuka-gets-grant-for-ophthalmic-formulation-for-protecting-keratoconjunctiva-from-dry-eye/ 2024-07-16T02:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athersys-gets-grant-for-method-of-administering-multipotent-stem-cells-without-immunosuppressive-treatment/ 2024-07-16T02:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/perrigo-co-gets-grant-for-nutritional-composition-for-cognitive-function-and-neuron-health/ 2024-07-16T02:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/morphosys-gets-grant-for-antibodies-for-treating-inflammatory-disorders-like-atopic-dermatitis-or-psoriasis/ 2024-07-16T02:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipca-laboratories-gets-grant-for-modified-lectin-protein-with-specific-amino-acid-sequence/ 2024-07-16T02:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ani-pharmaceuticals-gets-grant-for-method-of-storing-and-warming-sterile-corticotropin-composition/ 2024-07-16T02:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mayo-clinic-gets-grant-for-modified-measles-virus-with-reduced-susceptibility-to-antibody-neutralization/ 2024-07-16T02:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curevac-gets-grant-for-vaccine-for-stimulating-protective-anti-influenza-immune-response/ 2024-07-16T02:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/halozyme-therapeutics-gets-grant-for-modified-ph20-hyaluronidase-polypeptides-with-increased-stability-activity/ 2024-07-16T02:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inflarx-gets-grant-for-modulating-c5a-receptor-activity-for-treating-diseases/ 2024-07-16T02:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-gets-grant-for-treatment-of-hif-related-and-or-epo-related-diseases/ 2024-07-16T02:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syndax-pharmaceuticals-gets-grant-for-patient-selection-for-combination-therapy-using-hdac-inhibitor-and-anti-pd-1-antibody/ 2024-07-16T02:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/larimar-therapeutics-gets-grant-for-measuring-enzymatic-activity-of-frataxin-protein-generating-reactive-oxygen-species/ 2024-07-16T02:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allscripts-healthcare-solutions-gets-grant-for-clinical-decision-support-system-notifications-in-healthcare-record-system/ 2024-07-16T02:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-gets-grant-for-liquid-oral-pharmaceutical-composition-with-tadalafil-for-various-treatments/ 2024-07-16T02:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heidelberg-pharma-gets-grant-for-humanized-antibody-for-treating-prostate-cancer-and-other-diseases/ 2024-07-16T02:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avadel-pharmaceuticals-gets-grant-for-patent-granted-for-modified-release-ghb-formulation-for-narcolepsy/ 2024-07-16T02:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emergent-biosolutions-gets-grant-for-treatment-for-toxoplasma-gondii-infection-using-chimeric-polypeptides/ 2024-07-16T02:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amneal-pharmaceuticals-gets-grant-for-controlled-release-levodopa-compositions-for-treating-parkinson-s-disease/ 2024-07-16T02:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alector-gets-grant-for-patent-granted-for-siglec-9-ecd-fusion-molecules/ 2024-07-16T02:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boston-children-s-hospital-gets-grant-for-patent-granted-for-antisense-oligonucleotides-for-treating-genetic-disorders/ 2024-07-16T02:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antisense-therapeutics-gets-grant-for-method-for-treating-muscular-dystrophy-with-inhibitory-oligonucleotide/ 2024-07-16T02:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-gets-grant-for-treatment-of-desmoid-tumor-with-nirogacestat/ 2024-07-16T02:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innocare-pharma-gets-grant-for-patent-granted-for-crystalline-form-of-specific-chemical-compound/ 2024-07-16T02:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/children-s-medical-center-gets-grant-for-patent-granted-for-chimeric-vegf-binding-protein-treatment-method/ 2024-07-16T02:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-highly-concentrated-low-viscosity-liquid-pharmaceutical-formulation-for-injection/ 2024-07-16T02:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/unity-biotechnology-gets-grant-for-selective-elimination-of-senescent-cells-in-fibrotic-liver/ 2024-07-16T02:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcus-biosciences-gets-grant-for-solid-form-of-compound-i/ 2024-07-16T02:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocuphire-pharma-gets-grant-for-highly-pure-phentolamine-mesylate-with-specific-xrpd-pattern/ 2024-07-16T02:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-gets-grant-for-activating-compounds-for-pyruvate-kinase-r/ 2024-07-16T02:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-gets-grant-for-treating-amyloidosis-associated-with-ttr-using-gene-editing/ 2024-07-16T02:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-gets-grant-for-genome-editing-system-for-altering-target-nucleic-acid/ 2024-07-16T02:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexon-gets-grant-for-method-of-inhibiting-synapse-loss-using-anti-c1q-antibody/ 2024-07-16T02:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shenzhen-hepalink-pharmaceutical-group-gets-grant-for-berberine-compositions-for-treating-various-diseases/ 2024-07-16T02:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celldex-therapeutics-gets-grant-for-monoclonal-antibody-for-treating-eosinophil-related-gastrointestinal-disorders/ 2024-07-16T02:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-gets-grant-for-humanized-anti-cd45-antibodies-for-pharmaceutical-compositions/ 2024-07-16T02:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acadia-pharmaceuticals-gets-grant-for-treating-prader-willi-syndrome-with-pde4-inhibitor/ 2024-07-16T02:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-gets-grant-for-treatment-of-progressive-neurodegenerative-diseases-with-ibudilast/ 2024-07-16T02:48:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-gets-grant-for-treatment-and-diagnosis-of-peripheral-t-cell-lymphoma-using-nkp46/ 2024-07-16T02:48:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-gets-grant-for-resin-molding-apparatus-with-resin-supply-and-collection-mechanism/ 2024-07-16T02:48:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/northwest-biotherapeutics-gets-grant-for-cell-culture-system-with-symmetrical-fluid-flow-channels/ 2024-07-16T02:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-gets-grant-for-antibodies-binding-to-5t4-for-cancer-therapy/ 2024-07-16T02:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-patent-granted-for-cbl-b-inhibitors-for-immune-system-modulation/ 2024-07-16T02:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-gets-grant-for-motion-tracking-system-adjusting-method-using-gyroscope-sensors/ 2024-07-16T02:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kobayashi-pharmaceutical-gets-grant-for-interdental-cleaning-tool-with-varying-bristle-and-body-hardness/ 2024-07-16T02:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-gets-grant-for-method-of-treating-heart-failure-with-omecamtiv-mecarbil-dose-adjustment/ 2024-07-16T02:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-gets-grant-for-t-cell-modulatory-polypeptides-for-immune-response-modulation/ 2024-07-16T02:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-gets-grant-for-monoclonal-antibody-for-treating-staphylococcus-aureus-infection/ 2024-07-16T02:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-gets-grant-for-pharmaceutical-composition-for-treating-diseases/ 2024-07-16T02:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abcellera-biologics-gets-grant-for-transgenic-mouse-with-long-hcdr3-immunoglobulin-library-production/ 2024-07-16T02:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rapt-therapeutics-gets-grant-for-crystalline-form-of-ccr4-antagonist-compound/ 2024-07-16T02:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shanghai-junshi-bioscience-gets-grant-for-isotope-enriched-compounds-for-drug-delivery-modulation/ 2024-07-16T02:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spruce-biosciences-gets-grant-for-treatment-of-congenital-adrenal-hyperplasia-cah-using-crf1-receptor-antagonist/ 2024-07-16T02:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-gets-grant-for-crystalline-forms-of-pharmaceutical-compound/ 2024-07-16T02:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c4-therapeutics-gets-grant-for-degronimers-for-in-vivo-protein-degradation/ 2024-07-16T02:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-gets-grant-for-method-of-molecular-scaffold-hopping-using-preemptible-computing-instances/ 2024-07-16T02:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atea-pharmaceuticals-gets-grant-for-treatment-of-human-host-infected-with-rna-viruses/ 2024-07-16T02:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revolution-medicines-gets-grant-for-macrocyclic-compounds-modulating-biological-processes-by-binding-to-proteins/ 2024-07-16T02:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldeyra-therapeutics-gets-grant-for-intravitreal-methotrexate-composition-for-treating-eye-diseases/ 2024-07-16T02:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ose-immunotherapeutics-gets-grant-for-patent-granted-for-manufacturing-ready-to-use-peptide-emulsion/ 2024-07-16T02:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abivax-gets-grant-for-treatment-of-inflammatory-diseases-in-various-organs/ 2024-07-16T02:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-gets-grant-for-polynucleotides-encoding-aadc-for-parkinson-s-disease-treatment/ 2024-07-16T02:47:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-gets-grant-for-therapeutic-composition-for-treating-diseases-using-modified-polynucleic-acid/ 2024-07-16T02:47:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmv-pharmaceuticals-gets-grant-for-deuterium-substituted-indoles-for-binding-mutant-p53-protein/ 2024-07-16T02:47:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-gets-grant-for-analyzing-and-treating-abaloparatide-samples-for-isomers/ 2024-07-16T02:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-bilayer-tablet-for-hiv-treatment-with-dolutegravir-and-rilpivirine/ 2024-07-16T02:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elanco-animal-health-gets-grant-for-polypeptides-for-treating-il13-and-il4-induced-conditions-in-animals/ 2024-07-16T02:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-gets-grant-for-method-for-expanding-and-administering-tumor-infiltrating-lymphocytes/ 2024-07-16T02:47:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-gets-grant-for-medication-delivery-device-with-rack-and-pinion-plunger-drive-system/ 2024-07-16T02:47:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-gets-grant-for-crystalline-form-of-rigosertib-sodium-designated-as-form-a/ 2024-07-16T02:47:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/humanwell-healthcare-group-gets-grant-for-bioavailable-liquid-composition-with-active-ingredients-for-pharmaceutical-use/ 2024-07-16T02:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geron-gets-grant-for-patent-granted-for-crystalline-solid-of-compound-of-formula-i/ 2024-07-16T02:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-gets-grant-for-crystalline-form-of-highly-pure-bortezomib/ 2024-07-16T02:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celltrion-gets-grant-for-stable-liquid-formulation-for-subcutaneous-antibody-administration/ 2024-07-16T02:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogaia-gets-grant-for-oxygen-adapted-strain-of-anaerobic-microorganism-for-probiotics/ 2024-07-16T02:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/karyopharm-therapeutics-gets-grant-for-treatment-of-disorders-associated-with-crm1-activity/ 2024-07-16T02:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-gets-grant-for-gene-therapy-for-friedreich-s-ataxia-using-aav-vector/ 2024-07-16T02:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-gets-grant-for-method-of-treating-opioid-dependence-with-alcohol-consumption/ 2024-07-16T02:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zeria-pharmaceutical-gets-grant-for-antibodies-binding-to-tnfa-with-modified-fcrn-binding/ 2024-07-16T02:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yield10-bioscience-gets-grant-for-transgenic-plants-with-enhanced-yield-and-seed-yield/ 2024-07-16T02:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zealand-pharma-gets-grant-for-compstatin-analogues-with-improved-binding-and-complement-inhibiting-activity/ 2024-07-16T02:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-gets-grant-for-inhibiting-coronavirus-replication-with-compound-of-formula-i/ 2024-07-16T02:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/twist-bioscience-gets-grant-for-covalently-linked-polymerase-and-phosphorylated-nucleoside-for-polynucleotide-synthesis/ 2024-07-16T02:47:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selecta-biosciences-gets-grant-for-chimeric-antigen-receptors-for-improved-cancer-cell-killing/ 2024-07-16T02:47:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crinetics-pharmaceuticals-gets-grant-for-patent-granted-for-oral-method-to-suppress-hormones/ 2024-07-16T02:47:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chong-kun-dang-pharmaceutical-gets-grant-for-patent-granted-for-1-3-4-oxadiazole-derivative-compound-inhibiting-hdac6/ 2024-07-16T02:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-gets-grant-for-topical-ophthalmic-formulation-for-treating-inflammatory-ocular-disease/ 2024-07-16T02:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kissei-pharmaceutical-gets-grant-for-treatment-of-endometriosis-associated-pain-with-gnrh-antagonist/ 2024-07-16T02:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hu-group-gets-grant-for-method-for-measuring-lectin-binding-substance-in-a-sample/ 2024-07-16T02:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csl-gets-grant-for-formulation-for-reconstituted-high-density-lipoprotein-with-lyophilization-stabilizer/ 2024-07-16T02:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amarin-corp-gets-grant-for-method-for-reducing-heart-failure-risk-with-ethyl-icosapentate/ 2024-07-16T02:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-telepresence-robot-with-social-behavior-and-emergency-response-capabilities/ 2024-07-16T02:46:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arvinas-gets-grant-for-bifunctional-compound-for-degrading-inhibiting-raf-target-protein/ 2024-07-16T02:46:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esperion-therapeutics-gets-grant-for-patent-granted-for-method-of-preparing-pharmaceutical-material/ 2024-07-16T02:46:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultragenyx-pharmaceutical-gets-grant-for-method-of-protecting-aav-viral-particles-during-heat-inactivation/ 2024-07-16T02:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grunenthal-gets-grant-for-pain-treatment-compound-inhibitor-of-nav1-8/ 2024-07-16T02:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-gets-grant-for-tamper-resistant-opioid-analgesic-extended-release-dosage-form/ 2024-07-16T02:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kineta-gets-grant-for-compounds-for-treating-proteostasis-dysfunction/ 2024-07-16T02:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-gets-grant-for-prenatal-diagnosis-of-medical-conditions-using-dna-methylation/ 2024-07-16T02:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-laboratories-international-gets-grant-for-method-for-removing-contaminant-material-from-oil-and-gas-equipment/ 2024-07-16T02:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sosei-group-gets-grant-for-agonists-of-muscarinic-m1-and-m4-receptors/ 2024-07-16T02:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athenex-gets-grant-for-oral-cancer-treatment-method-using-taxane-surfactant-mixture/ 2024-07-16T02:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-gets-grant-for-nucleic-acid-for-inhibiting-target-gene-expression/ 2024-07-16T02:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endo-international-gets-grant-for-patent-granted-for-recombinant-nucleic-acid-encoding-collagenase/ 2024-07-16T02:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-gets-grant-for-antibodies-binding-to-b-cell-maturation-antigen-bcma/ 2024-07-16T02:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycomimetics-gets-grant-for-treatment-of-cancer-using-e-selectin-antagonists/ 2024-07-16T02:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeutic-solutions-international-gets-grant-for-memory-loss-prevention-during-neuroinflammation-using-therapeutic-compositions/ 2024-07-16T02:46:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tonix-pharmaceuticals-holding-gets-grant-for-treatment-of-major-depressive-disorder-in-fibromyalgia-patients/ 2024-07-16T02:46:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-gets-grant-for-treatment-of-systemic-mastocytosis-with-crystalline-form-a-of-compound-i/ 2024-07-16T02:46:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kymera-therapeutics-gets-grant-for-targeted-protein-degradation-for-treating-protein-mediated-disorders/ 2024-07-16T02:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/singular-genomics-systems-gets-grant-for-method-of-detecting-rna-molecules-in-cells-or-tissues/ 2024-07-16T02:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-gets-grant-for-complex-of-anti-transferrin-receptor-antibody-linked-to-oligonucleotide/ 2024-07-16T02:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-gets-grant-for-method-of-preparing-1-cyano-nucleosides-from-compound-of-formula-ii-a/ 2024-07-16T02:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-gets-grant-for-patent-granted-for-cyclic-polypeptides-binding-to-pcsk9/ 2024-07-16T02:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-gets-grant-for-anti-cd39-antibody-inhibiting-human-cd39-enzymatic-activity/ 2024-07-16T02:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marinus-pharmaceuticals-gets-grant-for-treatment-of-tuberous-sclerosis-related-epilepsy-using-ganaxolone/ 2024-07-16T02:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucb-gets-grant-for-patent-granted-for-cyclic-polypeptides-binding-to-pcsk9/ 2024-07-16T02:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mochida-pharmaceutical-gets-grant-for-ready-to-use-sterile-alginate-aqueous-solution-preparation-with-storage-stability/ 2024-07-16T02:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biolinerx-gets-grant-for-large-scale-process-for-preparing-cyclic-peptide/ 2024-07-16T02:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-gets-grant-for-predictive-model-for-maintaining-cell-culture-quality-attributes/ 2024-07-16T02:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exelixis-gets-grant-for-dual-inhibitor-for-treating-castration-resistant-prostate-cancer-and-bone-metastases/ 2024-07-16T02:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evotec-gets-grant-for-ophthalmic-formulation-for-treating-eye-disorders-with-aflibercept/ 2024-07-16T02:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-menarini-industrie-farmaceutiche-riunite-gets-grant-for-method-and-apparatus-for-reducing-sample-volume/ 2024-07-16T02:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-gets-grant-for-apparatus-for-extracting-target-material-using-magnetic-bar-blocks/ 2024-07-16T02:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-gets-grant-for-antiviral-compound-for-treating-viral-infections/ 2024-07-16T02:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mersana-therapeutics-gets-grant-for-patent-granted-for-antibody-drug-conjugates-targeting-b7-h4/ 2024-07-16T02:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codexis-gets-grant-for-engineered-galactose-oxidase-enzyme-with-specific-amino-acid-substitutions/ 2024-07-16T02:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regeneron-pharmaceuticals-gets-grant-for-culture-media-composition-with-anti-vegf-proteins/ 2024-07-16T02:45:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-gets-grant-for-treatment-of-cataplexy-in-narcolepsy-with-reduced-ghb-dosage/ 2024-07-16T02:45:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioatla-gets-grant-for-method-of-evolving-therapeutic-proteins-in-eukaryotic-host-system/ 2024-07-16T02:45:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-gets-grant-for-live-attenuated-chikungunya-virus-vaccine/ 2024-07-16T02:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glenmark-pharmaceuticals-gets-grant-for-antibodies-binding-to-il1rap-for-diagnosis-and-treatment/ 2024-07-16T02:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-gets-grant-for-compound-for-treating-cns-related-disorders/ 2024-07-16T02:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-gets-grant-for-laser-assisted-dental-procedure-for-periodontal-tissue-regeneration/ 2024-07-16T02:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-gets-grant-for-packaging-system-for-ophthalmic-devices-with-ectoine-solution/ 2024-07-16T02:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mallinckrodt-gets-grant-for-identifying-premature-infants-likely-to-benefit-from-inhaled-nitric-oxide/ 2024-07-16T02:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takara-gets-grant-for-recombinant-fibronectin-fragment-for-efficient-stem-cell-proliferation/ 2024-07-16T02:45:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jiangsu-hengrui-medicine-gets-grant-for-anti-lag-3-antibody-for-inhibiting-tumor-cell-growth/ 2024-07-16T02:45:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daiichi-sankyo-gets-grant-for-method-for-producing-diarylpyridine-derivatives-using-novel-synthesis-method/ 2024-07-16T02:45:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insmed-gets-grant-for-treatment-of-lupus-nephritis-with-ins1007-compound/ 2024-07-16T02:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-gets-grant-for-developing-aav-capsids-for-gene-therapy-delivery/ 2024-07-16T02:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytomx-therapeutics-gets-grant-for-method-of-partially-reducing-and-conjugating-activatable-antibodies/ 2024-07-16T02:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-gets-grant-for-treatment-of-psoriatic-arthritis-with-tablet-containing-compound-1/ 2024-07-16T02:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-gets-grant-for-immune-response-stimulation-method-using-specific-compounds/ 2024-07-16T02:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-gets-grant-for-treating-benign-tumors-by-inhibiting-angiogenesis-with-masp-2-antibody/ 2024-07-16T02:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galapagos-gets-grant-for-treatment-of-inflammatory-disorders-using-specific-antibodies/ 2024-07-16T02:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-gets-grant-for-assessing-likelihood-of-chronic-thromboembolic-pulmonary-hypertension-using-imaging-study/ 2024-07-16T02:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-gets-grant-for-treatment-of-ovarian-cancer-using-hdac6-inhibitor-and-epothilone/ 2024-07-16T02:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jcr-pharmaceuticals-gets-grant-for-software-analyzing-fertilized-egg-images-for-transplantation-based-on-pronucleus-area/ 2024-07-16T02:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-gets-grant-for-bicyclic-heterocyclyl-kinase-enzyme-inhibitor-compounds/ 2024-07-16T02:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astrazeneca-gets-grant-for-method-for-managing-cholesterol-in-a-subject/ 2024-07-16T02:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/moderna-gets-grant-for-moderna-inc-patent-for-mrna-with-heterologous-utrs/ 2024-07-16T02:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nippon-shinyaku-gets-grant-for-measuring-container-for-dispensing-tablets/ 2024-07-16T02:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shionogi-gets-grant-for-antimicrobial-compound-for-lactamase-inhibition/ 2024-07-16T02:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-gets-grant-for-treatment-of-acute-depression-and-anxiety-using-lumateperone/ 2024-07-16T02:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-gets-grant-for-treatment-of-anhedonia-using-compound-a/ 2024-07-16T02:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grifols-gets-grant-for-treatment-of-aging-associated-diseases-using-benzodioxane-inhibitors/ 2024-07-16T02:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-gets-grant-for-quantitative-flow-analysis-of-coronary-tree-perfusing-myocardium/ 2024-07-16T02:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-gets-grant-for-treatment-of-diabetes-type-2-with-ultrarapid-acting-insulin/ 2024-07-16T02:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-gets-grant-for-detection-of-target-analyte-using-nanostructure-binding-partner-conjugates/ 2024-07-16T02:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipocine-gets-grant-for-oral-testosterone-replacement-therapy-for-hypogonadal-males/ 2024-07-16T02:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chiesi-farmaceutici-gets-grant-for-pharmaceutical-formulation-with-pde4-inhibitory-activity-for-inhalation/ 2024-07-16T02:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-gets-grant-for-modulating-adenosine-receptor-activity-for-treating-diseases/ 2024-07-16T02:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-pharmaceutical-gets-grant-for-drug-for-prevention-treatment-of-abhd6-associated-disease/ 2024-07-16T02:44:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-bispecific-antibody-treatment-for-cd20-expressing-cancer-in-humans/ 2024-07-16T02:44:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-gets-grant-for-modifying-polymeric-scaffold-to-enhance-lung-cell-attachment/ 2024-07-16T02:44:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deciphera-pharmaceuticals-gets-grant-for-treatment-of-c-kit-mediated-cancers-including-gist-using-specific-inhibitors/ 2024-07-16T02:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vanda-pharmaceuticals-gets-grant-for-treatment-of-multiple-sclerosis-using-ponesimod/ 2024-07-16T02:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organovo-gets-grant-for-bioprinted-model-for-assessing-renal-injury-and-function/ 2024-07-16T02:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cellectis-gets-grant-for-chimeric-antigen-receptor-car-for-5t4-positive-cells/ 2024-07-16T02:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogen-gets-grant-for-compounds-for-treating-disorders-responsive-to-ask1-inhibition/ 2024-07-16T02:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzo-biochem-gets-grant-for-method-of-assaying-for-24-s-hydroxycholesterol-in-samples/ 2024-07-16T02:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-gets-grant-for-patent-granted-for-dsrna-agent-inhibiting-expression-of-htt/ 2024-07-16T02:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascendis-pharma-gets-grant-for-auto-injector-for-administering-medicament-with-mixing-capabilities/ 2024-07-16T02:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-gets-grant-for-crispr-nuclease-composition-with-nuclear-localization-sequences/ 2024-07-16T02:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axsome-therapeutics-gets-grant-for-patent-granted-for-treating-migraine-with-meloxicam-and-rizatriptan/ 2024-07-16T02:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/santen-pharmaceutical-gets-grant-for-preventive-eye-drop-for-glaucoma-or-ocular-hypertension/ 2024-07-16T02:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/supernus-pharmaceuticals-gets-grant-for-method-of-making-morpholine-derivatives-for-pharmaceutical-use/ 2024-07-16T02:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligand-pharmaceuticals-gets-grant-for-liver-targeting-acetal-and-cyclic-acetal-compounds/ 2024-07-16T02:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inovio-pharmaceuticals-gets-grant-for-modified-consensus-mesothelin-antigen-protein/ 2024-07-16T02:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pacira-biosciences-gets-grant-for-cryogenic-method-for-treating-target-tissue-to-alleviate-pain/ 2024-07-16T02:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precision-biosciences-gets-grant-for-engineered-meganucleases-for-modifying-dystrophin-gene-in-duchenne-muscular-dystrophy/ 2024-07-16T02:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ionis-pharmaceuticals-gets-grant-for-compound-for-reducing-dmpk-mrna-and-protein-expression/ 2024-07-16T02:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merus-gets-grant-for-novel-pd-1-binding-domain-with-high-affinity-for-treatment/ 2024-07-16T02:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-gets-grant-for-combination-therapy-for-increasing-t-cell-activation-in-cancer/ 2024-07-16T02:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corcept-therapeutics-gets-grant-for-method-of-treating-hyperglycemia-in-cushing-s-syndrome-with-mifepristone/ 2024-07-16T02:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cara-therapeutics-gets-grant-for-oral-formulation-for-kappa-opioid-receptor-agonist-delivery/ 2024-07-16T02:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipsen-gets-grant-for-treatment-for-bone-cancer-induced-allodynia-using-non-cytotoxic-protease/ 2024-07-16T02:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocryst-pharmaceuticals-gets-grant-for-treatment-of-zika-virus-infection-using-compound-of-formula-i/ 2024-07-16T02:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astellas-pharma-gets-grant-for-treating-cell-death-in-a-subject-after-surgery/ 2024-07-16T02:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-gets-grant-for-irak-inhibitors-for-treating-diseases/ 2024-07-16T02:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pfizer-gets-grant-for-ret-kinase-inhibitors-for-treating-diseases/ 2024-07-16T02:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanofi-gets-grant-for-treatment-of-acid-sphingomyelinase-deficiency-using-enzyme-replacement-therapy/ 2024-07-16T02:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viatris-gets-grant-for-biometric-based-video-game-control-system/ 2024-07-16T02:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bicycle-therapeutics-gets-grant-for-treatment-of-cancer-using-heterotandem-bicyclic-peptide-complex/ 2024-07-16T02:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/haisco-pharmaceutical-group-gets-grant-for-pharmaceutical-formulation-excluding-reducing-sugars/ 2024-07-16T02:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-johnson-gets-grant-for-ultrasonic-surgical-system-with-wrench-assembly-for-tissue-capture/ 2024-07-16T02:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vertex-pharmaceuticals-gets-grant-for-production-of-cells-for-treating-high-blood-sugar-levels/ 2024-07-16T02:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-gets-grant-for-production-of-diosmin-and-hesperidin-by-modified-microorganism/ 2024-07-16T02:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-gets-grant-for-method-for-determining-spectrophotometer-suitability-for-protein-concentration-measurement/ 2024-07-16T02:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccinex-gets-grant-for-treatment-of-autoimmune-and-inflammatory-diseases-using-anti-cxcl13-antibodies/ 2024-07-16T02:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biontech-gets-grant-for-tlr7-agonist-compound-for-inducing-cytokines/ 2024-07-16T02:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurobindo-pharma-gets-grant-for-solid-dispersion-of-naloxegol-oxalate/ 2024-07-16T02:43:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-gets-grant-for-semiconductor-wafer-mapping-apparatus-with-edge-detection/ 2024-07-16T02:43:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hisamitsu-pharmaceutical-gets-grant-for-quantitative-determination-of-amphetacarbamate-in-drug-containing-polymer-matrix/ 2024-07-16T02:43:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delix-plans-further-trials-with-neuroplastogen-after-positive-phase-i-data/ 2024-07-15T17:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-looks-to-add-a-ninth-indication-for-jak-inhibitor-rinvoq/ 2024-07-19T08:06:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/conflict-means-millions-of-children-are-missing-vaccinations-un-says/ 2024-07-15T15:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nona-alaya-bio-for-car-t/ 2024-12-18T16:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/exploring-melbournes-booming-life-sciences-sector/ 2024-07-15T11:59:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ausperbio-funding-chb/ 2024-07-15T09:22:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mabwell-9mw2821-fda/ 2024-07-15T08:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astra-zeneca-tagrisso-canada-nsclc/ 2024-07-15T08:11:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crossject-secures-funding-from-french-government-for-needle-free-platform/ 2024-07-12T16:29:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-closes-1-3bn-eyebio-acquisition-plans-pivotal-trial-for-lead-asset/ 2024-07-12T15:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/explainer-labour-has-been-elected-in-the-uk-now-what-2/ 2024-07-12T14:32:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-rolls-out-more-convenient-ocrevus-injection-for-multiple-sclerosis/ 2024-07-12T13:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-global-rights-foreseen-biotechnology-fs001/ 2024-07-12T10:34:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-askbio-ab-1005-pd/ 2024-07-12T10:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pan-cancer-t-seed-extension-round/ 2024-07-12T07:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/barda-tiba-biotech-therapeutics-influenza/ 2024-07-12T07:36:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-asserts-its-place-in-atopic-dermatitis-space-with-yellow-jersey-acquisition/ 2024-07-11T18:36:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/can-a-super-pill-help-shrink-big-pharmas-climate-footprint/ 2024-07-15T17:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merz-wins-185m-bid-for-bankrupt-acorda-assets-and-increases-us-workforce-by-50/ 2024-07-11T16:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspect-wins-72-75m-from-canadian-government-for-bioprinted-pipeline/ 2024-07-11T16:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/after-adcom-rejection-fda-rebuffs-novo-nordisks-once-weekly-insulin/ 2024-07-11T15:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/join-the-revolution-of-on-dose-authentication/ 2024-10-07T14:18:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-boehringer-ingelheim-plans-sustainability-work-for-the-long-term/ 2024-07-16T11:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ausperbios-ahb-137-china-chb/ 2024-07-11T10:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biotech-survey-highlights-where-industry-can-focus-for-a-thriving-future/ 2024-07-15T16:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hong-kong-leqembi-alzheimers/ 2024-07-11T10:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rgenta-ind-rgt-61159-cancers/ 2024-07-11T08:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmassetx-fdas-ibd/ 2024-07-11T08:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arcutis-bags-fda-approval-for-atopic-dermatitis-cream-after-delay/ 2024-07-10T17:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-ebglyss-for-atopic-dermatitis-patients/ 2024-07-10T14:32:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/longeveron-scores-rmat-designation-for-alzheimers-cell-therapy/ 2024-12-18T14:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-pfizer-drug-discovery/ 2024-07-10T10:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vistagen-patents-ph80-migraine/ 2024-07-10T10:17:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orladeyo-peru-hae-prevention/ 2024-07-10T08:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/integrichain-acquires-fcs/ 2024-07-10T08:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionctura-expands-pi3k-inhibitor-programme-to-nsclc/ 2024-07-09T16:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iteos-and-gsk-hit-enrolment-milestone-with-phase-iii-tigit-lung-cancer-trial/ 2024-07-09T16:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-relaunches-refillable-wet-amd-implant-two-years-after-recall/ 2024-07-10T16:37:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scirhom-autoimmune-diseases-treatments/ 2024-07-09T10:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiho-arcus-quemliclustat-asia/ 2024-07-09T10:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ligand-apeiron-biologics/ 2024-07-09T08:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-mitsubishi-mrna-vaccines/ 2024-07-09T08:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-bolsters-ibd-portfolio-with-3-2bn-morphic-acquisition/ 2024-07-08T17:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharma-group-reprimands-novo-nordisk-for-undisclosed-payments/ 2024-07-08T15:39:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-antengene-xpovio/ 2024-07-08T10:17:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myricx-bio-secures-114m/ 2024-07-08T10:10:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascentage-olverembatinib-approval-macau/ 2024-07-08T08:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-malaria-medicine-launch/ 2024-07-08T08:10:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/can-3110-candel-therapeutics-high-grade-glioma-likelihood-of-approval/ 2025-01-21T17:03:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ictcar-028-innovative-cellular-therapeutics-hematological-tumor-likelihood-of-approval/ 2025-01-21T17:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dalfampridine-ir-solaxa-spinocerebellar-ataxia-sca-likelihood-of-approval/ 2025-01-21T16:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-2389-astrazeneca-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2024-07-05T18:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-310-crispr-therapeutics-homozygous-familial-hypercholesterolemia-hofh-likelihood-of-approval/ 2024-07-05T18:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-310-crispr-therapeutics-heterozygous-familial-hypercholesterolemia-hefh-likelihood-of-approval/ 2024-07-05T18:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-310-crispr-therapeutics-hypertriglyceridemia-likelihood-of-approval/ 2024-07-05T18:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-310-crispr-therapeutics-mixed-dyslipidemia-likelihood-of-approval/ 2024-07-05T18:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cagrilintide-semaglutide-novo-nordisk-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-21T16:53:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kb-408-krystal-biotech-alpha-1-antitrypsin-deficiency-a1ad-likelihood-of-approval/ 2024-07-05T18:21:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-uterine-cancer-likelihood-of-approval/ 2024-07-05T17:40:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-07-05T17:40:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-gastric-cancer-likelihood-of-approval/ 2024-07-05T17:40:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-bladder-cancer-likelihood-of-approval/ 2024-07-05T17:40:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-colon-cancer-likelihood-of-approval/ 2024-07-05T17:39:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T17:39:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-prostate-cancer-likelihood-of-approval/ 2024-07-05T17:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-cervical-cancer-likelihood-of-approval/ 2024-07-05T17:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-lung-cancer-likelihood-of-approval/ 2024-07-05T17:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hf-158k1-highfield-biopharmaceuticals-ovarian-cancer-likelihood-of-approval/ 2024-07-05T17:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-tagrisso-plus-chemotherapy-wins-eu-approval-for-nsclc/ 2024-07-08T20:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-labour-government-backs-pharma-reform-in-uk/ 2024-07-08T21:15:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-sells-its-share-in-car-t-cell-therapy-to-iaso-bio-for-18-equity/ 2024-07-09T08:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-addresses-current-gap-in-copd-biologics-landscape/ 2024-07-09T08:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/labour-government-uk-election-2024-clinical-trials/ 2024-07-05T11:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pendopharm-deal-hypoparathyroidism/ 2024-07-05T10:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/philogen-sun-pharma-melanoma/ 2024-07-05T10:11:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-life-science-industry-optimistically-embraces-labour-victory/ 2024-07-05T11:44:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ean-2024-sublingual-apomorphine/ 2024-07-04T16:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosenic-patent-ato-sepsis/ 2024-07-05T08:30:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-fda-vabysmo-approval/ 2024-07-05T08:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aflibercept-biosimilar-lupin-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/ 2024-07-05T06:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/influenza-trivalent-vaccine-novavax-seasonal-influenza-likelihood-of-approval/ 2024-07-04T23:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/others-eyenovia-keratoconjunctivitis-sicca-dry-eye-likelihood-of-approval/ 2024-12-29T17:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ynk-105-yinuoke-cancer-anorexia-cachexia-syndrome-likelihood-of-approval/ 2024-07-04T23:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mr-139-viatris-blepharitis-likelihood-of-approval/ 2024-07-04T23:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lucarg-39d-legend-biotech-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T07:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lucarg-39d-legend-biotech-follicular-lymphoma-likelihood-of-approval/ 2024-09-09T07:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lucarg-39d-legend-biotech-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T07:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-07-04T23:26:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-epithelial-ovarian-cancer-likelihood-of-approval/ 2024-07-04T23:26:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-peritoneal-cancer-likelihood-of-approval/ 2024-07-04T23:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-fallopian-tube-cancer-likelihood-of-approval/ 2024-07-04T23:26:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-04T23:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-endometrial-cancer-likelihood-of-approval/ 2024-07-04T23:25:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-pancreatic-cancer-likelihood-of-approval/ 2024-07-04T23:25:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-cervical-cancer-likelihood-of-approval/ 2024-07-04T23:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-4170156-eli-lilly-and-co-colorectal-cancer-likelihood-of-approval/ 2024-07-04T23:24:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xc-8-valenta-pharm-dry-cough-likelihood-of-approval/ 2024-07-04T23:24:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xc-8-valenta-pharm-acute-upper-respiratory-tract-infections-likelihood-of-approval/ 2024-07-04T23:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xc-8-valenta-pharm-viral-respiratory-tract-infection-likelihood-of-approval/ 2024-07-04T23:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xc-8-valenta-pharm-acute-bronchitis-likelihood-of-approval/ 2024-07-04T23:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hsp-638-zhejiang-boyiao-biopharmaceutical-graves-ophthalmopathy-likelihood-of-approval/ 2024-07-04T23:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-immunoglobulin-g4-related-disease-igg4-rd-likelihood-of-approval/ 2024-07-04T23:22:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-primary-sjogren-s-syndrome-likelihood-of-approval/ 2024-07-04T23:22:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-idiopathic-thrombocytopenic-purpura-immune-thrombocytopenic-purpura-likelihood-of-approval/ 2024-07-04T23:22:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-idiopathic-inflammatory-myopathy-iim-likelihood-of-approval/ 2024-07-04T23:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-interstitial-lung-diseases-diffuse-parenchymal-lung-disease-likelihood-of-approval/ 2024-07-04T23:21:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-primary-biliary-cholangitis-primary-biliary-cirrhosis-likelihood-of-approval/ 2024-07-04T23:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-systemic-sclerosis-scleroderma-likelihood-of-approval/ 2024-07-04T23:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-systemic-lupus-erythematosus-likelihood-of-approval/ 2024-07-04T23:20:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bh-002-essen-biotech-rheumatoid-arthritis-likelihood-of-approval/ 2024-07-04T23:20:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyb-004-guangzhou-patronus-biotech-herpes-zoster-shingles-likelihood-of-approval/ 2024-07-04T23:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/srg-514-surge-therapeutics-ductal-carcinoma-in-situ-likelihood-of-approval/ 2024-12-29T17:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/srg-514-surge-therapeutics-breast-cancer-likelihood-of-approval/ 2024-12-29T17:31:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cannabidiol-3-avata-biosciences-epilepsy-likelihood-of-approval/ 2024-07-04T23:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-360-takeda-pharmaceutical-type-2-narcolepsy-narcolepsy-without-cataplexy-likelihood-of-approval/ 2024-07-04T23:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-360-takeda-pharmaceutical-idiopathic-hypersomnia-ih-likelihood-of-approval/ 2024-07-04T23:18:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scb-002-scbio-pancreatic-cancer-likelihood-of-approval/ 2024-07-04T23:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pembrolizumab-biosimilar-sandoz-group-melanoma-likelihood-of-approval/ 2024-12-29T17:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gd-iexo-003-guidon-pharmaceutics-acute-ischemic-stroke-likelihood-of-approval/ 2024-07-04T23:17:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3938577-eli-lilly-and-co-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-07-04T23:17:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dapagliflozin-zibotentan-astrazeneca-proteinuria-likelihood-of-approval/ 2024-12-29T17:31:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dapagliflozin-zibotentan-astrazeneca-liver-cirrhosis-likelihood-of-approval/ 2024-12-29T17:31:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dapagliflozin-zibotentan-astrazeneca-chronic-kidney-disease-chronic-renal-failure-likelihood-of-approval/ 2024-12-29T17:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iam-1363-iambic-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-04T23:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iam-1363-iambic-therapeutics-bladder-cancer-likelihood-of-approval/ 2024-07-04T23:15:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iam-1363-iambic-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-07-04T23:15:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iam-1363-iambic-therapeutics-breast-cancer-likelihood-of-approval/ 2024-07-04T23:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gim-531-georgiamune-solid-tumor-likelihood-of-approval/ 2024-07-04T23:14:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gim-531-georgiamune-metastatic-melanoma-likelihood-of-approval/ 2024-07-04T23:14:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thb-335-third-harmonic-bio-chronic-urticaria-or-hives-likelihood-of-approval/ 2024-07-04T23:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/br-01t-brise-pharmaceuticals-chronic-low-back-pain-clbp-likelihood-of-approval/ 2024-12-29T17:31:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mesenchymal-stem-cell-msc-cell-energy-life-sciences-group-lung-injury-likelihood-of-approval/ 2024-12-29T17:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cannabidiol-avata-biosciences-schizophrenia-likelihood-of-approval/ 2024-07-04T23:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cannabidiol-avata-biosciences-epilepsy-likelihood-of-approval/ 2024-07-04T23:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-007-first-condor-group-gastroesophageal-ge-junction-carcinomas-likelihood-of-approval/ 2024-12-29T17:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-007-first-condor-group-esophageal-cancer-likelihood-of-approval/ 2024-12-29T17:31:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-007-first-condor-group-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyaluronan-fragment-nakhia-impex-chronic-skin-inflammation-likelihood-of-approval/ 2024-12-29T17:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6344-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-07-04T23:11:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6344-f-hoffmann-la-roche-melanoma-likelihood-of-approval/ 2024-07-04T23:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zka-03-lee-s-pharmaceutical-herpes-zoster-shingles-likelihood-of-approval/ 2024-07-04T23:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/et-600-eton-pharmaceuticals-diabetes-insipidus-likelihood-of-approval/ 2024-07-04T23:10:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemivibart-invivyd-leukemia-likelihood-of-approval/ 2024-09-09T07:20:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemivibart-invivyd-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T07:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemivibart-invivyd-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T07:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemivibart-invivyd-multiple-myeloma-kahler-disease-likelihood-of-approval/ 2024-09-09T07:20:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jlp-2004-jeil-pharmaceutical-back-pain-likelihood-of-approval/ 2024-07-04T23:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jlp-2004-jeil-pharmaceutical-rheumatoid-arthritis-likelihood-of-approval/ 2024-07-04T23:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jlp-2004-jeil-pharmaceutical-osteoarthritis-likelihood-of-approval/ 2024-07-04T23:08:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ezetimibe-obicetrapib-newamsterdam-pharma-company-atherosclerosis-likelihood-of-approval/ 2024-09-09T07:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lb-1908-legend-biotech-metastatic-adenocarcinoma-of-the-pancreas-likelihood-of-approval/ 2024-07-04T23:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vx-993-vertex-pharmaceuticals-pain-likelihood-of-approval/ 2024-09-09T07:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ath-1105-athira-pharma-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2024-07-04T23:06:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6524-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-07-04T23:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6524-f-hoffmann-la-roche-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-04T23:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bw-00112-shanghai-argo-pharmaceutical-hypertriglyceridemia-likelihood-of-approval/ 2024-12-29T17:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-6581-novo-nordisk-steatohepatitis-likelihood-of-approval/ 2024-07-04T23:05:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caba-201-cabaletta-bio-myasthenia-gravis-likelihood-of-approval/ 2024-12-29T17:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultracar-t-saxocell-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2024-07-04T23:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/u-87-shanghai-unicar-therapy-bio-medicine-technology-solid-tumor-likelihood-of-approval/ 2024-12-29T17:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yl-202-suzhou-medilink-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-12-29T17:30:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tin-816-novartis-acute-renal-failure-arf-acute-kidney-injury-likelihood-of-approval/ 2024-12-29T17:30:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senaparib-temozolomide-impact-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-12-29T17:30:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senaparib-temozolomide-impact-therapeutics-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-12-29T17:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senaparib-temozolomide-impact-therapeutics-solid-tumor-likelihood-of-approval/ 2024-12-29T17:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senaparib-temozolomide-impact-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senaparib-temozolomide-impact-therapeutics-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-2716-orsobio-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2024-12-29T17:30:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-2716-orsobio-hypertriglyceridemia-likelihood-of-approval/ 2024-12-29T17:30:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlc-2716-orsobio-familial-hypercholesterolemia-type-ii-hyperlipoproteinemia-likelihood-of-approval/ 2024-12-29T17:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gc-203-shanghai-juncell-therapeutics-metastatic-ovarian-cancer-likelihood-of-approval/ 2024-09-09T07:19:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:30:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-b-cell-chronic-lymphocytic-leukemia-likelihood-of-approval/ 2024-12-29T17:30:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-12-29T17:30:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-follicular-lymphoma-likelihood-of-approval/ 2024-12-29T17:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-mantle-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ctx-112-crispr-therapeutics-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:29:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shra-2102-jiangsu-hengrui-medicine-solid-tumor-likelihood-of-approval/ 2024-12-29T17:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vorinostat-unravel-biosciences-rett-syndrome-likelihood-of-approval/ 2024-12-29T17:29:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crd-740-cardurion-pharmaceuticals-diastolic-heart-failure-hfpef-likelihood-of-approval/ 2024-07-04T22:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crd-740-cardurion-pharmaceuticals-systolic-heart-failure-likelihood-of-approval/ 2024-07-04T22:58:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-24714-beigene-solid-tumor-likelihood-of-approval/ 2024-07-04T22:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hrs-8427-jiangsu-hengrui-medicine-lung-infections-likelihood-of-approval/ 2024-12-29T17:29:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-metastatic-biliary-tract-cancer-likelihood-of-approval/ 2024-07-04T22:56:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-04T22:55:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-bladder-cancer-likelihood-of-approval-2/ 2024-07-04T22:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/azd-9574-astrazeneca-bladder-cancer-likelihood-of-approval/ 2024-07-04T19:42:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-colorectal-cancer-likelihood-of-approval/ 2024-07-04T19:42:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-gastric-cancer-likelihood-of-approval/ 2024-07-04T19:42:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tqh-2722-chia-tai-tianqing-pharmaceutical-group-rhinosinusitis-likelihood-of-approval/ 2024-07-04T19:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cg-p5-peptide-caregen-wet-neovascular-exudative-macular-degeneration-likelihood-of-approval/ 2024-07-04T19:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dcc-3084-deciphera-pharmaceuticals-melanoma-likelihood-of-approval/ 2024-12-29T17:29:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dcc-3084-deciphera-pharmaceuticals-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neldaleucel-marker-therapeutics-cns-lymphoma-likelihood-of-approval/ 2024-07-04T19:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dcc-3084-deciphera-pharmaceuticals-lung-cancer-likelihood-of-approval/ 2024-12-29T17:29:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-253-kymera-therapeutics-merkel-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neldaleucel-marker-therapeutics-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-07-04T19:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-253-kymera-therapeutics-uveal-melanoma-likelihood-of-approval/ 2024-12-29T17:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-253-kymera-therapeutics-adenoid-cystic-carcinoma-acc-likelihood-of-approval/ 2024-12-29T17:29:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-253-kymera-therapeutics-sarcomas-likelihood-of-approval/ 2024-12-29T17:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kt-253-kymera-therapeutics-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:29:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bsi-04702-obi-pharma-solid-tumor-likelihood-of-approval/ 2024-12-29T17:29:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bsi-04702-obi-pharma-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bsi-04702-obi-pharma-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:28:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bsi-04702-obi-pharma-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:28:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-peritoneal-cancer-likelihood-of-approval/ 2024-09-09T07:18:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-metastatic-bile-duct-cancer-likelihood-of-approval/ 2024-09-09T07:18:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-fallopian-tube-cancer-likelihood-of-approval/ 2024-09-09T07:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-solid-tumor-likelihood-of-approval/ 2024-09-09T07:18:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-endometrial-cancer-likelihood-of-approval/ 2024-09-09T07:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-metastatic-breast-cancer-likelihood-of-approval/ 2024-09-09T07:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hc-7366-hibercell-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-07-04T19:34:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hc-7366-hibercell-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-07-04T19:34:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methotrexate-pharmaceutical-and-cosmetic-solutions-rheumatoid-arthritis-likelihood-of-approval/ 2024-12-29T17:28:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hc-7366-hibercell-myelodysplastic-syndrome-likelihood-of-approval/ 2024-07-04T19:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/favezelimab-pembrolizumab-merck-esophageal-squamous-cell-carcinoma-escc-likelihood-of-approval/ 2024-12-29T17:28:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cnp-106-cour-pharmaceuticals-development-myasthenia-gravis-likelihood-of-approval/ 2024-07-04T19:32:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shr-2002-jiangsu-hengrui-medicine-advanced-malignancy-likelihood-of-approval/ 2024-12-29T17:28:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/loxo-435-loxo-oncology-solid-tumor-likelihood-of-approval/ 2024-07-04T19:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/loxo-435-loxo-oncology-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/ 2024-07-04T19:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-rectal-cancer-likelihood-of-approval/ 2024-07-04T19:31:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-neuroendocrine-tumors-likelihood-of-approval/ 2024-07-04T19:31:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-pancreatic-cancer-likelihood-of-approval/ 2024-07-04T19:30:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-gastric-cancer-likelihood-of-approval/ 2024-07-04T19:30:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-07-04T19:30:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chm-2101-chimeric-therapeutics-colon-cancer-likelihood-of-approval/ 2024-07-04T19:30:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zolmitriptan-passport-technologies-inc-usa-migraine-likelihood-of-approval/ 2024-07-04T19:29:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stsa-1002-staidson-beijing-biopharmaceuticals-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-anca-vasculitis-likelihood-of-approval/ 2024-12-29T17:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pa-317-persongen-biotherapeutics-suzhou-anaplastic-large-cell-lymphoma-alcl-likelihood-of-approval/ 2024-09-09T07:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pa-317-persongen-biotherapeutics-suzhou-peripheral-t-cell-lymphomas-ptcl-likelihood-of-approval/ 2024-09-09T07:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pa-317-persongen-biotherapeutics-suzhou-angioimmunoblastic-t-cell-lymphoma-aitl-immunoblastic-lymphadenopathy-likelihood-of-approval/ 2024-09-09T07:18:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pa-317-persongen-biotherapeutics-suzhou-acute-lymphoblastic-lymphoma-likelihood-of-approval/ 2024-09-09T07:18:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/levothyroxine-sodium-xeris-biopharma-hypothyroidism-likelihood-of-approval/ 2024-07-04T19:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/debio-4228-debiopharm-international-metastatic-prostate-cancer-likelihood-of-approval/ 2024-07-04T19:26:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hr-011408-jiangsu-hengrui-medicine-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-12-29T17:28:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hrs-2398-shanghai-hengrui-pharmaceuticals-solid-tumor-likelihood-of-approval/ 2024-07-04T19:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/octreotide-er-debiopharm-international-acromegaly-likelihood-of-approval/ 2024-09-09T07:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blm-07d1-systimmune-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-12-29T17:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gr-1802-genrix-shanghai-biopharmaceutical-seasonal-allergic-rhinitis-likelihood-of-approval/ 2024-12-29T17:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/im-250-innovative-molecules-simplexvirus-hsv-infections-likelihood-of-approval/ 2024-12-29T17:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zongertinib-boehringer-ingelheim-international-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-12-29T17:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zongertinib-boehringer-ingelheim-international-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-12-29T17:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tub-040-tubulis-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:28:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zongertinib-boehringer-ingelheim-international-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:28:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tub-040-tubulis-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:28:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/loxo-338-loxo-oncology-b-cell-chronic-lymphocytic-leukemia-likelihood-of-approval/ 2024-12-29T17:27:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/icp-248-innocare-pharma-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-12-29T17:27:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-fresenius-kabi-swissbiosim-glucocorticoid-induced-osteoporosis-likelihood-of-approval/ 2024-12-29T17:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-fresenius-kabi-swissbiosim-giant-cell-tumor-of-bone-likelihood-of-approval/ 2024-12-29T17:27:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-fresenius-kabi-swissbiosim-bone-metastasis-likelihood-of-approval/ 2024-12-29T17:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-fresenius-kabi-swissbiosim-post-menopausal-osteoporosis-likelihood-of-approval/ 2024-12-29T17:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-biosimilar-fresenius-kabi-swissbiosim-osteoporosis-likelihood-of-approval/ 2024-12-29T17:27:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyx-201-pyxis-oncology-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-07-04T19:20:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ac-101-accro-bioscience-suzhou-inflammatory-bowel-disease-likelihood-of-approval/ 2024-12-29T17:27:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyx-201-pyxis-oncology-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-07-04T19:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gc-101-shanghai-juncell-therapeutics-cervical-cancer-likelihood-of-approval/ 2024-12-29T17:27:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-cd7-car-t-cells-icell-gene-therapeutics-t-cell-acute-lymphocytic-leukemia-t-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2024-09-09T07:17:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-cd7-car-t-cells-icell-gene-therapeutics-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T07:17:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-cd7-car-t-cells-icell-gene-therapeutics-acute-lymphoblastic-lymphoma-likelihood-of-approval/ 2024-09-09T07:17:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evo-756-evommune-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2024-12-29T17:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fosigotifator-calico-life-sciences-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2024-12-29T17:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nvl-655-nuvalent-non-small-cell-lung-cancer-likelihood-of-approval-2/ 2024-12-29T17:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nmtcnp-8-neomatrix-therapeutics-burns-likelihood-of-approval/ 2024-07-04T19:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-303-abbvie-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-12-29T17:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sar-445877-sanofi-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:27:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-303-abbvie-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:26:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-303-abbvie-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asp-2802-astellas-pharma-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2024-07-04T19:12:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asp-2802-astellas-pharma-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-07-04T19:12:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asp-2802-astellas-pharma-t-cell-lymphomas-likelihood-of-approval/ 2024-07-04T19:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asp-2802-astellas-pharma-follicular-lymphoma-likelihood-of-approval/ 2024-07-04T19:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glecirasib-jacobio-pharmaceuticals-group-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2024-12-29T17:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asp-2802-astellas-pharma-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-07-04T19:11:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vrt-106-guangzhou-virotech-pharmaceutical-metastatic-melanoma-likelihood-of-approval/ 2024-12-29T17:26:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vrt-106-guangzhou-virotech-pharmaceutical-metastatic-prostate-cancer-likelihood-of-approval/ 2024-12-29T17:26:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psilocybin-tryptamine-therapeutics-fibromyalgia-fibromyalgia-syndrome-likelihood-of-approval/ 2024-12-29T17:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vrt-106-guangzhou-virotech-pharmaceutical-metastatic-hepatocellular-carcinoma-hcc-likelihood-of-approval/ 2024-12-29T17:26:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gq-1010-biohaven-epithelial-tumor-likelihood-of-approval/ 2024-09-09T07:16:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psilocybin-tryptamine-therapeutics-irritable-bowel-syndrome-likelihood-of-approval/ 2024-12-29T17:26:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-01-seed-health-irritable-bowel-syndrome-likelihood-of-approval/ 2024-07-04T19:09:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tgrx-678-shenzhen-targetrx-chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-likelihood-of-approval/ 2024-07-04T19:09:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shr-1819-jiangsu-hengrui-medicine-sinusitis-likelihood-of-approval/ 2024-12-29T17:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vip-236-vincerx-pharma-endometrial-cancer-likelihood-of-approval/ 2024-12-29T17:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bdc-3042-bolt-biotherapeutics-melanoma-likelihood-of-approval/ 2024-07-04T19:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bdc-3042-bolt-biotherapeutics-renal-cell-carcinoma-likelihood-of-approval/ 2024-07-04T19:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/balcinrenone-dapagliflozin-astrazeneca-chronic-kidney-disease-chronic-renal-failure-likelihood-of-approval/ 2024-12-29T17:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dc-853-dice-therapeutics-inflammation-likelihood-of-approval/ 2024-12-29T17:26:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-2910-ono-pharmaceutical-diabetic-neuropathy-likelihood-of-approval/ 2024-12-29T17:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dc-853-dice-therapeutics-autoimmune-disorders-likelihood-of-approval/ 2024-12-29T17:26:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orx-750-centessa-pharmaceuticals-type-1-narcolepsy-narcolepsy-with-cataplexy-likelihood-of-approval/ 2024-12-29T17:26:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zna-1041-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-07-04T19:05:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hpn-01-hepanova-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2024-07-04T19:05:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-rezetecan-jiangsu-hengrui-medicine-solid-tumor-likelihood-of-approval/ 2024-12-29T17:25:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osivelotor-pfizer-liver-failure-hepatic-insufficiency-likelihood-of-approval/ 2024-12-29T17:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-764524-boehringer-ingelheim-international-non-proliferative-diabetic-retinopathy-npdr-likelihood-of-approval/ 2024-07-04T19:03:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cln-619-cullinan-therapeutics-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cdr-404-cdr-life-solid-tumor-likelihood-of-approval/ 2024-12-29T17:25:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ltp-001-novartis-pulmonary-arterial-hypertension-likelihood-of-approval/ 2024-07-04T19:03:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6115-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-07-04T19:02:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deltacel-kiromic-biopharma-squamous-cell-carcinoma-likelihood-of-approval/ 2024-07-04T19:01:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eciskafusp-alfa-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-07-04T19:01:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-nasopharyngeal-cancer-likelihood-of-approval/ 2024-12-29T17:25:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:25:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-hepatocellular-carcinoma-likelihood-of-approval/ 2024-12-29T17:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9041-novo-nordisk-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-07-04T18:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-280-takeda-pharmaceutical-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:25:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tak-280-takeda-pharmaceutical-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgba-445-beigene-solid-tumor-likelihood-of-approval/ 2024-12-29T17:25:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2024-07-04T18:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-3011-immvira-non-muscle-invasive-bladder-cancer-nmibc-superficial-bladder-cancer-likelihood-of-approval/ 2024-12-29T17:25:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-relapsed-multiple-myeloma-likelihood-of-approval/ 2024-07-04T18:56:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-refractory-multiple-myeloma-likelihood-of-approval/ 2024-07-04T18:56:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-lupus-nephritis-likelihood-of-approval/ 2024-07-04T18:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2024-07-04T18:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yte-001-bristar-immunotech-biotechnology-hemophagocytic-lymphohistiocytosis-likelihood-of-approval/ 2024-12-29T17:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bcma-cd19-icell-gene-therapeutics-systemic-lupus-erythematosus-likelihood-of-approval/ 2024-07-04T18:55:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clofutriben-sparrow-pharmaceuticals-cushing-s-syndrome-likelihood-of-approval/ 2024-09-09T07:16:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alg-009-aligos-therapeutics-liver-fibrosis-likelihood-of-approval/ 2024-07-04T18:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clofutriben-sparrow-pharmaceuticals-adrenocortical-hyperfunction-likelihood-of-approval/ 2024-09-09T07:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hb-admscs-hope-biosciences-parkinson-s-disease-likelihood-of-approval/ 2024-12-29T17:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wtx-124-werewolf-therapeutics-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-12-29T17:24:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wtx-124-werewolf-therapeutics-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:25:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ociperlimab-beigene-squamous-non-small-cell-lung-cancer-likelihood-of-approval-2/ 2024-09-09T07:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wtx-124-werewolf-therapeutics-hepatocellular-carcinoma-likelihood-of-approval/ 2024-12-29T17:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apr-1051-aprea-therapeutics-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-07-04T18:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ociperlimab-beigene-cervical-cancer-likelihood-of-approval/ 2024-09-09T07:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apr-1051-aprea-therapeutics-solid-tumor-likelihood-of-approval/ 2024-07-04T18:50:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apr-1051-aprea-therapeutics-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-07-04T18:50:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apr-1051-aprea-therapeutics-breast-cancer-likelihood-of-approval/ 2024-07-04T18:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apr-1051-aprea-therapeutics-ovarian-cancer-likelihood-of-approval/ 2024-07-04T18:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rilvegostomig-astrazeneca-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-12-29T17:24:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-0780-astrazeneca-familial-hypercholesterolemia-type-ii-hyperlipoproteinemia-likelihood-of-approval/ 2024-12-29T17:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hh-2853-shanghai-haihe-biopharma-soft-tissue-sarcoma-likelihood-of-approval/ 2024-12-29T17:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ad-209-addpharma-idiopathic-essential-hypertension-likelihood-of-approval-2/ 2024-07-04T18:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aj-201-avenue-therapeutics-kennedy-s-disease-spinal-and-bulbar-muscular-atrophy-likelihood-of-approval/ 2024-07-04T18:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-star-t-cells-bristar-immunotech-biotechnology-acute-lymphocytic-leukemia-all-acute-lymphoblastic-leukemia-likelihood-of-approval/ 2024-07-04T18:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/son-1010-sonnet-biotherapeutics-head-and-neck-cancer-likelihood-of-approval/ 2024-12-29T17:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lbl-007-beigene-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lixudebart-alentis-therapeutics-idiopathic-pulmonary-fibrosis-likelihood-of-approval/ 2024-12-29T17:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kpg-818-kangpu-biopharmaceuticals-systemic-lupus-erythematosus-likelihood-of-approval/ 2024-07-04T18:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lixudebart-alentis-therapeutics-liver-fibrosis-likelihood-of-approval/ 2024-12-29T17:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cabometyx-exelixis-gastroesophageal-ge-junction-carcinomas-likelihood-of-approval/ 2024-12-29T17:08:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vrn-07-oric-pharmaceuticals-solid-tumor-likelihood-of-approval/ 2024-12-29T17:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cabometyx-exelixis-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cabometyx-exelixis-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-12-29T17:08:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-3745417-gsk-solid-tumor-likelihood-of-approval/ 2024-07-04T18:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-aspart-amphastar-pharmaceuticals-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-07-04T18:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-aspart-amphastar-pharmaceuticals-type-2-diabetes-likelihood-of-approval/ 2024-07-04T18:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wms-1-wellmarker-bio-bile-duct-cancer-cholangiocarcinoma-likelihood-of-approval/ 2024-12-29T17:08:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wms-1-wellmarker-bio-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:08:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wms-1-wellmarker-bio-head-and-neck-cancer-likelihood-of-approval/ 2024-12-29T17:08:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wms-1-wellmarker-bio-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nhwd-870-ningbo-wenda-pharmaceutical-technology-nut-midline-carcinoma-nmc-or-nuclear-protein-in-testis-midline-carcinoma-likelihood-of-approval/ 2024-12-29T17:08:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wms-1-wellmarker-bio-colon-cancer-likelihood-of-approval/ 2024-12-29T17:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amt-191-uniqure-fabry-disease-likelihood-of-approval/ 2024-12-29T17:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dapiglutide-zealand-pharma-obesity-likelihood-of-approval/ 2024-07-04T18:40:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boxr-1030-sotio-biotech-squamous-cell-carcinoma-likelihood-of-approval/ 2024-07-04T18:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6237-f-hoffmann-la-roche-obesity-likelihood-of-approval/ 2024-07-04T18:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/linperlisib-shanghai-yingli-pharmaceutical-t-cell-leukemia-likelihood-of-approval/ 2024-12-29T17:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/io-108-immune-onc-therapeutics-bile-duct-cancer-cholangiocarcinoma-likelihood-of-approval/ 2024-09-09T07:15:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/il2-cd25-bristol-myers-squibb-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2024-12-29T17:08:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/io-108-immune-onc-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-09-09T07:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/io-108-immune-onc-therapeutics-solid-tumor-likelihood-of-approval/ 2024-09-09T07:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg-010-sorafenib-metagone-biotech-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg-010-sorafenib-metagone-biotech-non-small-cell-lung-carcinoma-likelihood-of-approval/ 2024-12-29T17:08:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg-010-sorafenib-metagone-biotech-hepatocellular-carcinoma-likelihood-of-approval/ 2024-12-29T17:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg-010-sorafenib-metagone-biotech-solid-tumor-likelihood-of-approval/ 2024-12-29T17:08:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ponsegromab-pfizer-congestive-heart-failure-heart-failure-likelihood-of-approval/ 2024-12-29T17:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg-010-sorafenib-metagone-biotech-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nizubaglustat-azafaros-tay-sachs-disease-likelihood-of-approval-2/ 2024-12-29T17:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sotorasib-amgen-metastatic-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:07:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tti-101-tvardi-therapeutics-breast-cancer-likelihood-of-approval/ 2024-12-29T17:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sot-102-sotio-biotech-metastatic-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/botensilimab-agenus-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/m-701-wuhan-yzy-biopharma-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:07:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sot-102-sotio-biotech-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:07:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muzastotug-adagene-suzhou-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anhydrous-enol-oxaloacetate-metvital-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2024-12-29T17:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mevrometostat-pfizer-follicular-lymphoma-likelihood-of-approval/ 2024-12-29T17:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mevrometostat-pfizer-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-12-29T17:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bevacizumab-outlook-therapeutics-branch-retinal-vein-occlusion-likelihood-of-approval/ 2024-12-29T17:07:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dresbuxelimab-akeso-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-04T18:31:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tqb-3525-chia-tai-tianqing-pharmaceutical-group-metastatic-ovarian-cancer-likelihood-of-approval/ 2024-09-09T07:14:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bevacizumab-outlook-therapeutics-diabetic-macular-edema-likelihood-of-approval/ 2024-12-29T17:07:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sinbaglustat-idorsia-pharmaceutical-tay-sachs-disease-likelihood-of-approval/ 2024-07-04T18:29:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tqb-3525-chia-tai-tianqing-pharmaceutical-group-cervical-cancer-likelihood-of-approval-2/ 2024-09-09T07:14:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atr-258-atrogi-type-2-diabetes-likelihood-of-approval/ 2024-07-04T18:28:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bria-ots-briacell-therapeutics-metastatic-breast-cancer-likelihood-of-approval/ 2024-09-09T07:14:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zodasiran-arrowhead-pharmaceuticals-mixed-dyslipidemia-likelihood-of-approval/ 2024-12-29T17:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zodasiran-arrowhead-pharmaceuticals-familial-hypercholesterolemia-type-ii-hyperlipoproteinemia-likelihood-of-approval/ 2024-12-29T17:07:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tarlatamab-amgen-neuroendocrine-cancer-likelihood-of-approval/ 2024-12-29T17:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laromestrocel-longeveron-alzheimer-s-disease-likelihood-of-approval/ 2024-12-29T17:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jaktinib-hydrochloride-suzhou-zelgen-biopharmaceutical-alopecia-areata-likelihood-of-approval/ 2024-12-29T17:06:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tarlatamab-amgen-prostate-cancer-likelihood-of-approval/ 2024-12-29T17:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selenium-sulfide-azura-ophthalmics-meibomian-blepharitis-likelihood-of-approval/ 2024-12-29T17:06:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gemcitabine-hydrochloride-fujifilm-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumorad-spago-nanomedical-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-12-29T17:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pucotenlimab-lepu-biopharma-nasopharyngeal-cancer-likelihood-of-approval/ 2024-12-29T17:06:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pucotenlimab-lepu-biopharma-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-12-29T17:06:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-12-29T17:06:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-12-29T17:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:06:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-solid-tumor-likelihood-of-approval/ 2024-12-29T17:06:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986301-bristol-myers-squibb-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmd-026-phoenix-molecular-designs-metastatic-breast-cancer-likelihood-of-approval/ 2024-12-29T17:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmd-026-phoenix-molecular-designs-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-12-29T17:06:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tlsg-1-innomedica-parkinson-s-disease-likelihood-of-approval/ 2024-07-04T18:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/can-3110-candel-therapeutics-recurrent-malignant-glioma-likelihood-of-approval/ 2024-12-29T17:06:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ict-01-imcheck-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zelenectide-pevedotin-bicycle-therapeutics-urethral-cancer-likelihood-of-approval/ 2024-12-29T17:05:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zelenectide-pevedotin-bicycle-therapeutics-ureter-cancer-likelihood-of-approval/ 2024-12-29T17:06:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zelenectide-pevedotin-bicycle-therapeutics-bladder-cancer-likelihood-of-approval/ 2024-12-29T17:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zelenectide-pevedotin-bicycle-therapeutics-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-12-29T17:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/berberine-ursodeoxycholate-hightide-therapeutics-type-2-diabetes-likelihood-of-approval/ 2024-12-29T17:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9499-novo-nordisk-liver-diseases-likelihood-of-approval/ 2024-07-04T18:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acit-1-cancer-vaccines-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2024-07-04T18:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lcb-71-cstone-pharmaceuticals-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T07:13:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lcb-71-cstone-pharmaceuticals-ovarian-cancer-likelihood-of-approval/ 2024-09-09T07:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lcb-71-cstone-pharmaceuticals-pancreatic-cancer-likelihood-of-approval/ 2024-09-09T07:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-efsitora-alfa-eli-lilly-and-co-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-12-29T17:05:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alintegimod-7-hills-pharma-malignant-pleural-mesothelioma-likelihood-of-approval/ 2024-12-29T17:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navacaprant-hydrochloride-neumora-therapeutics-bipolar-ii-disorder-likelihood-of-approval/ 2024-09-09T07:13:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alintegimod-7-hills-pharma-renal-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:05:38+00:00 daily 0.2